Recombinant Anti-CD40 (Clone G28.5)
Applications | FC, IHC, IP |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone G28.5)
Applications | FC, IHC, IP |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-Complement Receptor 1 & 2 (Clone 7G6)
Applications | Bl, FC, IHC, IP, WB |
Reactivities | Mouse |
Conjugation | Unconjugated |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
Applications | FC |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone FGK45)
Applications | FC, FN, WB |
Reactivities | Mouse |
Conjugation | Unconjugated |
Recombinant Anti-CD19 (Clone HD37)
Applications | Bl, FC, IF, IHC, IP |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD70 (Clone TAN1-6)
Applications | Bl, FC, IF, WB |
Reactivities | Mouse |
Conjugation | Unconjugated |
Recombinant Anti-CD20 (Clone 18B12)
Applications | FC, FN, IF, WB |
Reactivities | Mouse |
Conjugation | Unconjugated |
USD 630.00
2 Weeks
Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))
Applications | Bl, FC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD45R (Clone RA3-6B2)
Applications | FC, IF, IHC |
Reactivities | Mouse |
Conjugation | Unconjugated |
Recombinant Anti-CD19 (Clone 4G7)
Applications | FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD19 (Clone FMC63)
Applications | FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone 5D12)
Applications | Bl, ELISA, FC, IHC, IP |
Reactivities | Human, Cynomolgus, Monkey |
Conjugation | Unconjugated |
Recombinant Anti-CD40L (Clone AT161-8)
Applications | FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD79a (Clone ZL7-4)
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD40L (Clone AT161-10)
Applications | ELISA |
Reactivities | Human |
Conjugation | Unconjugated |